MORE►
M.D
[iStockphoto: White Bear Studio]
Frisco-Based Ayass Bioscience Aims to ‘Neutralize’ Peanut Allergies
by David Seeley | Nov 14, 2024
Researchers at Ayass Bioscience have discovered and developed AYA22A aptamers, molecular compounds that target and bind to peanut proteins that cause most peanut allergy reactions in the U.S. The technology could potentially lead to treatment options for the sensitivity, along with allergy-friendly peanut products and other solutions, the company says.
by Dallas Innovates | Staff Report |
Sep 12, 2022
From obesity to cardiovascular disease, we live in an era of unprecedented diet-related health problems. But Dr. Albin, who leads the Culinary Medicine program at UT Southwestern, and her team are trying to cook up a solution by reviewing programs at medical schools across the U.S.
The review of programs by UT Southwestern researchers has been published in Academic Medicine, the journal of the Association of American Medical Colleges.
MORE►
by David Seeley |
May 6, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Techstars Physical Health Fort Worth Accelerator, Divurgent, IKS Health, Invitation Homes, Comerica, New Friends New Life, Lennox, Trademark Property, Golden State Foods, and Catapult Health.
MORE►
by Alex Edwards |
Sep 24, 2020
Using alternating magnetic fields in technology created by UTSW researchers, Solenic Medical aims to provide a better way to treat prosthetic joint infections than the current standard of care. Recently, the startup received an FDA designation of a Breakthrough Device.
MORE►
